IDT Biologika and Exothera collaborate to scale-up viral vaccine manufacturing 03-Mar-2022 By Rachel Arthur IDT Biologika and Exothera S.A. are working together to develop a large-scale manufacturing process for viral vector-based vaccines.
Recipharm grows biologics business as it acquires Arranta Bio and Vibalogics 18-Feb-2022 By Jane Byrne Contract development and manufacturing organization (CDMO), Recipharm, is now better placed to serve the advanced therapy medicinal products (ATMPs) market through two deals announced today.
